development of the China market. Support services include China management team recruitment, Chinese clinical trials, CFDA regulatory filing and approval guidance, strategic planning and business development.

Elite Capital RMB Fund targets China domestic life sciences companies. They target both larger companies at the cusp of IPO, as well as smaller companies with strong product portfolio and great upside. In addition, the RMB fund will provide capital to incubate leading technologies and products from overseas in China.